References
- Bazhin, A.V., Philippov, P.P., and Karakhanova, S., 2016. Reactive oxygen species in cancer biology and anticancer therapy. Oxidative Medicine and Cellular Longevity, 2016, 4197815.
- Chang, Y., et al., 2014. Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells. Tumor Biology, 35 (2), 1075–1082.
- Degli Esposti, M. and McLennan, H., 1998. Mitochondria and cells produce reactive oxygen species in virtual anaerobiosis: relevance to ceramide-induced apoptosis. FEBS Letters, 430 (3), 338–342.
- Dikalov, S.I. and Harrison, D.G., 2014. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxidants and Redox Signaling, 20 (2), 372–382.
- Farah, M.A., et al., 2016. Silver nanoparticles synthesized from Adenium obesum leaf extract induced DNA damage, apoptosis and autophagy via generation of reactive oxygen species. Colloids and Surfaces B, Biointerfaces, 141, 158–169.
- Hu, T., et al., 2016. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World Journal of Gastroenterology, 22 (30), 6876–6889.
- Jiang, Y., et al., 2010. Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology, 62 (6), 573–583.
- Kang, X.H., et al., 2017. Degradation of Mcl-1 through GSK-3beta activation regulates apoptosis induced by bufalin in non-small cell lung cancer H1975 cells. Cellular Physiology and Biochemistry, 41 (5), 2067–2076.
- Liu, F., et al., 2016. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway. Oncotarget, 7 (8), 8896–8907.
- Liu, X., et al., 2016. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of Ethnopharmacology, 193, 538–545.
- Pelicano, H., et al., 2003. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J. Biol. Chem, 278 (39), 37832–37839.
- Qi, J., et al., 2014. Toad glandular secretions and skin extractions as anti-inflammatory and anticancer agents. Evidence-Based Complementary and Alternative Medicine, 2014, 312684.
- Qiu, D.Z., et al., 2013. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. BMC Complement Alternative Medicine, 13, 185.
- Scherz-Shouval, R., et al., 2010. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proceedings of the National Academy of Sciences of the United States of America, 107 (43), 18511–18516.
- Sheng, X., et al., 2016. Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells. International Journal of Oncology, 49 (4), 1513–1524.
- Siegel, R.L., et al., 2017. Colorectal cancer statistics, 2017. CA: A Cancer Journal for Clinicians, 67 (3), 177–193.
- Sivaprasad, U. and Basu, A., 2008. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. Journal of Cellular and Molecular Medicine, 12 (4), 1265–1271.
- Tian, X., et al., 2015. Bufalin induces mitochondria-dependent apoptosis in pancreatic and oral cancer cells by downregulating hTERT expression via activation of the JNK/p38 pathway. Evidence-Based Complementary and Alternative Medicine, 2015, 546210.
- Wang, J., et al., 2015. Bufalin inhibits HCT116 colon cancer cells and its orthotopic xenograft tumor in mice model through genes related to apoptotic and PTEN/AKT pathways. Gastroenterology Research and Practice, 2015, 457193.
- Watabe, M., et al., 1997. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells. Cancer Research, 57 (15), 3097–3100. :
- Wu, S.H., et al., 2014. Bufalin induces cell death in human lung cancer cells through disruption of DNA damage response pathways. The American Journal of Chinese Medicine, 42 (3), 729–742.
- Xie, C.-M., et al., 2011. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radical Biology and Medicine, 51 (7), 1365–1375.
- Yan, S., et al., 2014. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Anti-Cancer Drugs, 25 (6), 683–689.
- Yeh, J.Y., et al., 2003. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. The Prostate, 54 (2), 112–124.
- Yu, C.H., et al., 2008. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Science, 99 (12), 2467–2476.
- Zhai, X., et al., 2014. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line. Journal of Traditional Chinese Medicine = Chung i Tsa Chih Ying Wen Pan, 34 (6), 678–683.
- Zhang, X., et al., 2017. Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 94, 627–635.
- Zhu, Z., et al., 2012. Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression. Acta Haematologica, 128 (3), 144–150.
- Zhu, Z., et al., 2012. Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells. World Journal of Surgical Oncology, 10, 228.